Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Opinion Article, J Clin Exp Oncol Vol: 10 Issue: 11

Indications, Efficacy and Safety of Chemoport in Children: A Study from a Tertiary Center


Introduction: Long term venous access is cumbersome in the pediatric age group due to thinner caliber veins, easy compromisation of venous integrity and less co-operative nature of children. Few studies are available that look at the use of chemoports in children and their complications. Method: A retrospective analysis of children who underwent chemoport insertion from January 2008 to December 2017 was carried out. Results: A total of 159 children (169 chemoports) were included in the study. The most common indication for chemoport insertion was acute lymphoblastic leukemia (52%). The mean chemoport days were 746±666 days. Among the 169 chemoports, 55% underwent chemoport removal as they completed the treatment. Chemoport hasn’t been removed in 35% patients as 28% patients are still under treatment and 7% patients expired during the treatment. Sixteen (0.1 per 1000 chemoport days) patients had a premature removal of chemoport.

Keywords: Arrhythmias, Decubitus, Imaging modality

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination

Recommended Conferences

International Conference on Clinical Nephrology

Las Vegas, USA

Media Partners